# Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention

> **NCT06095765** · PHASE3 · RECRUITING · sponsor: **AZ Sint-Jan AV** · enrollment: 2770 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Colchicine 0.5 MG Oral Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06095765
- **Lead sponsor:** AZ Sint-Jan AV
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-29
- **Primary completion:** 2027-11-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 2770 (ESTIMATED)
- **Last updated:** 2024-03-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06095765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06095765, "Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06095765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*